An early crew return signals heightened health risks in space, potentially delaying scheduled missions and impacting NASA’s commercial launch partnerships.
NASA is weighing an unprecedented early return for International Space Station Expedition 11 after canceling a planned Thursday spacewalk, citing an unspecified medical issue affecting one crew member. The decision marks a rare public acknowledgment of a health concern in orbit, with the astronaut reported to be in stable condition but the situation described as serious.
Crew 11, launched in August, comprises Zena Cardman, Mike Fininky, Japan’s Kamiya Yui, and Russia’s Oleg Platininov. Their six‑to‑eight‑month stint was slated to conclude in May, yet the medical issue has prompted NASA to evaluate all options, including a premature return. The canceled EVA, a six‑and‑a‑half‑hour operation to install new hardware, would have tied Fininky with veteran EVA astronauts, underscoring the gravity of scrapping the activity.
NASA’s spokesperson emphasized safety as the top priority, stating the agency “does not use language lightly” when discussing early mission termination. The episode echoes prior EVA cancellations—2024’s suit‑discomfort scrub and a 2021 pinched‑nerve incident—highlighting the physical toll of extravehicular work. Cardman’s presence on this flight also reflects earlier schedule reshuffles after the Boeing Starliner delays that forced a nine‑month rescue mission for astronauts Butch and Sunny.
If NASA proceeds with an early return, it could ripple through downstream launch manifests, affect commercial crew contracts, and force a reassessment of health monitoring protocols for long‑duration missions. The incident may also delay critical hardware upgrades slated for the ISS, influencing both scientific output and the station’s operational timeline.
Comments
Want to join the conversation?
Loading comments...